Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2017, Article ID 9642027, 9 pages
https://doi.org/10.1155/2017/9642027
Research Article

Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia

1Unified Women’s Clinical Research, 1100-C South Stratford Road, Suite 310, Winston-Salem, NC 27103, USA
2Luitpold Pharmaceuticals, Inc., 800 Adams Ave, Suite 100, Norrisville, PA 19403, USA
3Department of Obstetrics and Gynecology, Temple University School of Medicine, Philadelphia, PA 19140, USA

Correspondence should be addressed to Melvin H. Seid; moc.chdeifinu@dies.nivlem

Received 7 November 2016; Revised 17 February 2017; Accepted 21 February 2017; Published 13 April 2017

Academic Editor: Duran Canatan

Copyright © 2017 Melvin H. Seid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Brugnara, “Iron deficiency and erythropoiesis: new diagnostic approaches,” Clinical Chemistry, vol. 49, no. 10, pp. 1573–1578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. N. J. Kassebaum, R. Jasrasaria, M. Naghavi et al., “A systematic analysis of global anemia burden from 1990 to 2010,” Blood, vol. 123, no. 5, pp. 615–624, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Friedman, Z. Chen, P. Ford et al., “Iron deficiency anemia in women across the life span,” Journal of Women's Health, vol. 21, no. 12, pp. 1282–1289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Jimenez, S. Kulnigg-Dabsch, and C. Gasche, “Management of iron deficiency anemia,” Gastroenterology and Hepatology, vol. 11, no. 4, pp. 241–250, 2015. View at Google Scholar · View at Scopus
  5. World Health Organization, Assessing the Iron Status of Populations, WHO, Geneva, Switzerland, 2007.
  6. L. M. Bodnar, K. S. Scanlon, D. S. Freedman, A. M. Siega-Riz, and M. E. Cogswell, “High prevalence of postpartum anemia among low-income women in the United States,” American Journal of Obstetrics and Gynecology, vol. 185, no. 2, pp. 438–443, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Markova, A. Norgaard, K. J. Jorgensen, and J. Langhoff-Roos, “Treatment for women with postpartum iron deficiency anaemia,” Cochrane Database of Systemic Reviews, vol. 8, Article ID CD010861, 2015. View at Google Scholar
  8. M. Auerbach and J. W. Adamson, “How we diagnose and treat iron deficiency anemia,” American Journal of Hematology, vol. 91, no. 1, pp. 31–38, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Tolkien, L. Stecher, A. P. Mander, D. I. A. Pereira, and J. J. Powell, “Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis,” PLoS ONE, vol. 10, no. 2, Article ID e0117383, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Fishbane, V.-D. Ungureanu, J. K. Maesaka, C. J. Kaupke, V. Lim, and J. Wish, “The safety of intravenous iron dextran in hemodialysis patients,” American Journal of Kidney Diseases, vol. 28, no. 4, pp. 529–534, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Fishbane, “Safety in iron management,” American Journal of Kidney Diseases, vol. 41, supplement 5, pp. S18–S26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. G. M. Chertow, P. D. Mason, O. Vaage-Nilsen, and J. Ahlmén, “Update on adverse drug events associated with parenteral iron,” Nephrology Dialysis Transplantation, vol. 21, no. 2, pp. 378–382, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. A. Lyseng-Williamson and G. M. Keating, “Ferric carboxymaltose: a review of its use in iron-deficiency anaemia,” Drugs, vol. 69, no. 6, pp. 739–756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. E. Toblli and M. Angerosa, “Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose,” Drug Design, Development and Therapy, vol. 8, pp. 2475–2491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. B. Van Wyck, M. G. Martens, M. H. Seid, J. B. Baker, and A. Mangione, “Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial,” Obstetrics and Gynecology, vol. 110, no. 2, part 1, pp. 267–278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. B. Van Wyck, A. Mangione, J. Morrison, P. E. Hadley, J. A. Jehle, and L. T. Goodnough, “Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial,” Transfusion, vol. 49, no. 12, pp. 2719–2728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Seid, R. J. Derman, J. B. Baker, W. Banach, C. Goldberg, and R. Rogers, “Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial,” American Journal of Obstetrics and Gynecology, vol. 199, no. 4, pp. 435.e1–435.e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Breymann, F. Gliga, C. Bejenariu, and N. Strizhova, “Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia,” International Journal of Gynecology and Obstetrics, vol. 101, no. 1, pp. 67–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. C. F. Barish, T. Koch, A. Butcher, D. Morris, and D. B. Bregman, “Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials,” Anemia, vol. 2012, Article ID 172104, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Wolf, T. A. Koch, and D. B. Bregman, “Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women,” Journal of Bone and Mineral Research, vol. 28, no. 8, pp. 1793–1803, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Jüppner, M. Wolf, and I. B. Salusky, “FGF-23: more than a regulator of renal phosphate handling?” Journal of Bone and Mineral Research, vol. 25, no. 10, pp. 2091–2097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. Onken, D. B. Bregman, R. A. Harrington et al., “A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia,” Transfusion, vol. 54, no. 2, pp. 306–315, 2014. View at Publisher · View at Google Scholar · View at Scopus